$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
This study highlights a noninvasive, real-time, and highly sensitive method of quantifying mitochondrial health using a portable Resonance Raman Spectroscopy system that is comprised of a laser in a compact probe, connected with a fiber optic cable to a laser pump. This method used a 441 nm laser to excite mitochondria, which produce unique spectral signals depending on their oxidation state. Thus, RRS is able to quantify each state of mitochondria through their spectral signatures and compare the emitted spectra with pre-measured spectral libraries using regression analysis. A mitochondrial health metric was then created based on the ratio of reduced to total mitochondria: the Reduced Resonance Raman Mitochondrial Ratio (3RMR).
This paper focuses on demonstrating real-time changes in 3RMR as a function of oxygenation with native tissue without the need for sample processing. This was achieved through an oxygen stress test: after 5 min of continuous oxygenated perfusion, perfusion flow is paused for 5 min and restarted for another 5 min. 3RMR measurements are taken throughout the stress test. A stress test model, where we shift between ischemic and oxygenated periods, allows us to track continuous changes in mitochondrial redox states– and, by extension, mitochondrial function. In other words, the oxygen stress test allows us to track the trends in 3RMR as a function of oxygenation. Our group has attributed increasing 3RMR values to ischemic conditions, disrupting perfusion flow, which causes electrons passing through the ETC to build up, as O2 is not available as the final electron acceptor. This build-up of electrons causes a reduced state, which translates to an increase in 3RMR values. However, upon reintroduction of O2, healthy mitochondria are expected to resume ETC activity and recover to physiological redox states, as their structural and functional elements are intact.
As expected, in the present paper, a real-time, continuous increase in 3RMR was observed throughout the ischemic period (Figure 5A). Similarly, 3RMR gradually returns to optimal levels throughout the reperfusion period (Figure 5A). This real-time change in mitochondrial redox states is also visible in the spectral graph, as the mitochondrial peak shifts from oxidized (1371 cm-1) to reduced (1357 cm-1) states throughout the ischemic period, and returns to oxidized at the end of reperfusion (Figure 6). Other reduced RR marker peaks appear during the ischemic period, as well. Unlike traditional mitochondrial health assays, Resonance Raman is sensitive enough to quantify the redox states of complex III and complex IV, which could, and has provided, mechanistic insight into the specific impact of ischemia-reperfusion injuries to the ETC. In healthy mitochondria, electrons are passed through various complexes in the ETC, starting from complex I, until they reach O2 as the final electron acceptor. A pause in oxygen flow can shift each complex to a reduced state, as electrons get backed up along the ETC. As expected, a real-time increase was observed in 3RMR values of cIII and cIV upon the onset of ischemia. This indicates that the lack of O2 impacts the whole ETC, rather than a specific complex (Figure 5B). As we will discuss below, the sensitivity of RRS facilitates detailed mechanistic studies and informs the development of targeted therapies for IRI.
Traditionally, we also expect to observe elevated lactate levels in ischemic organs, since they rely on anaerobic metabolism in the absence of oxygen to produce ATP. Similarly, an increase in K+ levels was expected in damaged organs, since the membrane integrity of cells is disrupted, allowing an efflux of intercellular K+. Lastly, severely damaged cells may have lower metabolism, since their metabolic pathways are impacted by ischemia-induced metabolic waste and ROS, leading to a diminished consumption of oxygen. However, no changes in lactate, K+, or oxygen consumption are observed during or after the ischemic period. In fact, values do not indicate any cessation of oxygen flow, as they stay relatively consistent throughout the stress test (Figure 5B–D). In essence, using an oxygen stress test, this study shows that 3RMR values reflect shifts in mitochondrial redox states during ischemia-reperfusion more quickly, in real time, and more sensitively than traditional damage biomarkers (Figure 5). We recognize that this study compared 3RMR dynamics with indirect indicators of mitochondrial health, such as lactate and OCR, rather than more direct downstream comparators, such as NAD+/NADH and ATP. Although this study does not explicitly correlate changes in 3RMR to ATP/NADH concentrations, previous work9,14 has shown 3RMR to be predictive of changes in these downstream biomarkers. For instance, Nguyen et al.9 demonstrated that 3 h warm-ischemic (WI) livers with low 3RMR values (<10%) have significantly lower ATP concentrations and NAD/NADH ratios than 1 h WI livers (3RMR values of ~15%). Additionally, Jain et al.14 saw no significant differences in the NAD+/NADH ratio or EC in groups that had no significant differences in their 3RMR. They also observed the NAD+/NADH ratios and EC to be significantly different in 24 h cold-ischemic (CI) livers upon acellular perfusion in comparison to cellular perfusion, which also showed statistically significant 3RMR values. Taken together, these results demonstrate 3RMR values to reflect changes in more direct measures of mitochondrial and ETC function.
Even though this paper utilizes RRS throughout a 15-min perfusion to demonstrate the performance of the system, other published studies have demonstrated the utility of RRS in longitudinal studies. More specifically, in a previous work, we demonstrated that RRS complements traditional biomarkers throughout longer organ perfusions, as it provides insight into mitochondrial health and function that differ significantly from traditional methods. For instance, the study utilized RRS to assess the viability of transplantable (24 h SCS) and non-transplantable (72 h SCS) cold-ischemic rat livers throughout subnormothermic perfusion10. Although the initial response to oxygenation in both groups was similar, the 3RMR of non-transplantable livers increased with perfusion, while the 3RMR of transplantable liver remained consistent through SNMP. Similarly, potassium levels and overall weight gain for 72 h CI livers were higher throughout SNMP in comparison to 24 h CI livers. The study demonstrated RRS' utility in complementing traditional biomarkers throughout long perfusions. In another study, we utilized RRS to understand reoxygenation dynamics and metabolic recovery of cold-ischemic (CI) rat livers14. We perfused minimally ischemic (15 min of cold-ischemia) and 24-h cold-ischemic livers with either an acellular or an RBC-packed perfusate (pRBC). When 24-h CI livers were perfused with acellular perfusate, we observed a latent decrease in 3RMR compared to when perfused with pRBCs. The study attributed this delayed increase in 3RMR to the accumulation of electrons at the mitochondrial cytochromes during cold ischemia that can be rapidly transferred to the abundant oxygen molecules in the case of the pRBC-based perfusate. However, in combination with other markers of injury, we observe greater hepatic damage in 24 h CI livers perfused with pRBCs. The study concluded that measuring mitochondrial oxygenation in real time via RRS can provide insight into mitochondrial recovery, which could be beneficial for optimizing long perfusion strategies. In essence, the findings indicate that integrating traditional biomarkers (e.g., lactate, OCR, ATP) with RRS-driven insights into mitochondrial redox states and oxygenation dynamics provides a more comprehensive assessment of mitochondrial recovery.
Other studies have used RRS as a testbed for therapeutics that may mitigate ischemia-reperfusion injury to the ETC9. In prolonged periods of ischemia, electrons accumulate within the ETC, with the capacity for electrons to escape through the various complexes, especially during reperfusion. Understanding the redox state of individual complexes as a function of ischemia-reperfusion can offer a deeper understanding of the location of injury with potential for more targeted interventions. For instance, our group has utilized RRS to develop therapeutic interventions for complex-III dysfunction in warm-ischemic porcine livers. In a study conducted by Nguyen et al. (2026)9, 1 h and 3 h WI livers were placed onto SNMP for 3 h. As previously mentioned, three-hour WI livers are known to suffer from damage to the ETC, resulting in overoxidation and reduced metabolism. Although 3RMR values for fresh and 1 h WI livers were within the optimal range throughout the perfusion, we observed 3RMR values of 3 h WI livers to continuously drop, reaching below the optimal range (10%) at 3 h. Additionally, we observed no differences in the 3RMR values of cIV between either group, with cIV being fully oxidized in each group. The hyperoxidization of cIII, combined with a healthy redox state observed in cIV indicates reperfusion-induced overoxidation at complex III. Armed with this knowledge, Nyugen et al. (2026)9were able to select a therapeutic that could overcome the dysfunction of cIII: methylene blue (MB), which acts as an electron shuttle between cI and cytochrome c, bypassing cIII and transferring electrons directly to cIV. The 3RMR results reflected the therapeutic effect of MB on the mitochondria, as 3RMR values during SNMP of 3h WI livers increased to reflect electrons being transported directly to cIV, and hepatic metabolism restarting. The mitigating effect of MB was also validated by decreasing outflow lactate and improving oxygen consumption rates. In essence, the specificity of RRS enabled the development of a therapeutic pathway tailored to mitochondrial needs following warm ischemia.
Throughout this paper, we present Resonance Raman Spectroscopy as a noninvasive, real-time, and highly specific method to measure mitochondrial health. The study demonstrates how RRS can measure subtle shifts in redox states without disturbing the tissue before such physiological changes have downstream effects. However, it is important to note the several limitations of the Resonance Raman system. Firstly, RRS requires all molecules that are resonantly enhanced in a tissue to be identified and accounted for in the regression, with each molecule having different enhancement factors to account for relative signal strengths. Although we have created spectral libraries for all such components at a given wavelength and tissue, the user may need to create and validate new libraries for each tissue and wavelength of interest. Further, some tissues may have complicated spectral elements, which can make it challenging to measure mitochondrial cytochromes that exist in lower concentrations. For example, pig or human livers contain beta-carotene, and blood contains hemoglobin, which both have strong spectral signals that add to the number of spectral signatures RRS needs to account for in the regression. Lastly, the 441 nm laser used for these measurements has a beam diameter of 2 mm and a penetration depth of less than 1 mm. Such localized, surface measurements may promote sampling error, as differences in redox state in other parts of the organ may be overlooked. To overcome such challenges, measurements could be taken from biopsies taken from the core of the organ, or a multi-laser setup could enable measurements over a larger surface area to provide a more complete understanding of whole organ health.
In conclusion, we show that Resonance Raman Spectroscopy is sensitive to subtle changes in mitochondrial dynamics in comparison to blood-gas analytes. A detailed explanation of setting up and operating the system is provided here. We highlight the noninvasive, highly specific, and real-time evaluation nature of RRS, and explain how it could be used as a diagnostic and mechanistic approach. We also emphasize its use in developing specific therapeutic pathways for mitochondrial dysfunction. Future studies may focus on adapting the RRS system to evaluate mitochondrial health from biopsies, precision-cut tissue slices, or other tissue-derived products, including human tissue for translational research. The adoption of RRS offers a powerful approach in metabolic research, improving our understanding of cellular bioenergetic processes with greater ease than traditional methods.